Lacripep for Corneal Wound Healing Study

Conditions

• Corneal Epithelial Wound Healing

Eligibility Criteria

Sex

ALL

Age

21 Years - 55 Years

Healthy Volunteers

Not accepted

Interventions

• 0.00025% Lacripep ophthalmic solution and Placebo — DRUG
  Participant will receive Lacripep in one eye and placebo in the other eye at the same time.

Study Details

The objective of this study is to evaluate the safety and effectiveness of Lacripep as a therapy for superficial corneal injury repair after Photorefractive keratectomy (PRK).

Key Dates

Start date

May 23, 2025

Status verified

Feb 2026

Primary completion

Jun 30, 2027

Completion

Sep 30, 2027

Study Design

Enrollment

88 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Arms

• Experimental: Treatment
  Participants will receive Lacripep in one eye and placebo in the other eye at the same time.

Primary Outcome Measure

Efficacy of Lacripep [ Time Frame: Epithelial thickness assessment will be performed at 4 and 7 days postoperatively then at 1, 3 and 6 months postoperatively. ]

Central Contacts

• Zachary P Skurski, DO
  571-231-1670
  [email protected]
• Rose Sia
  [email protected]

Locations (1)

Find similar trials in Fort Belvoir, VA